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ABSTRACT
The impact of prenatal smoke exposure (PSE) on DNA methylation has been demonstrated in blood
samples from children of smoking mothers, but evidence for sex-dependent smoke-induced effects is
limited. As the identiﬁed differentially methylated genes can be associated with developmental processes,
and insulin-like growth factors (IGFs) play a critical role in prenatal tissue growth, we hypothesized that
PSE induces fetal programming of Igf1r and Igf1. Using a mouse model of smoking during pregnancy, we
show that PSE alters promoter methylation of Igf1r and Igf1 and deregulates their gene expression in lung
and liver of fetal (E17.5) and neonatal (D3) mouse offspring. By further comparing female versus male,
lung versus liver, or fetal versus neonatal time point, our results demonstrate that CpG site-speciﬁc
aberrant methylation patterns sex-dependently vary per organ and time point. Moreover, PSE reduces
gene expression of Igf1r and Igf1, dependent on organ, sex, and offspring’s age. Our results indicate that
PSE may be a source of organ-speciﬁc rather than general systemic fetal programming. This is exempliﬁed
here by gene promoter methylation and mRNA levels of Igf1r and Igf1, together with a sex- and organ-
speciﬁc naturally established correlation of both parameters that is affected by prenatal smoke exposure.
Moreover, the comparison of fetuses with neonates suggests a CpG site-dependent reversibility/
persistence of PSE-induced differential methylation patterns.
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Introduction
Smoking during pregnancy inﬂuences fetal development and
may compromise the offspring’s health during childhood, but
also later in life. These effects were shown in epidemiology (for
a review, see [1]) and in vivo experiments (see, for example,
[2,3]); however, the impact of prenatal smoke exposure (PSE)
on the actual developmental mechanisms and signaling path-
ways are not yet fully understood. Although respiratory effects
are the primarily investigated consequences in literature,
maternal smoking during pregnancy has also been causally
associated with adverse cardiovascular and metabolic outcomes
in the offspring (reviewed in [4]).
The fetal origins of disease hypothesis [5,6] links the impact
of environmental factors, epigenetic regulation, and prenatal
development, emphasizing the susceptibility of rapidly prolifer-
ating tissues to fetal programming. Modiﬁed DNA methylation
and PSE were previously linked in infant blood samples
(e.g., [7,8]); some methylation marks are persistent and can be
detected later in life [9]. Smoking-associated aberrant DNA
methylation patterns seem to be greater in girls than in boys
[10], but the cumulative effects of smoke exposure and
offspring’s sex on CpG site-speciﬁc methylation was rarely
investigated. Nevertheless, using a mouse model we previously
showed sex-dependent and CpG site-speciﬁc loss of Igf1r pro-
moter methylation together with reduced mRNA levels of Igf1r
and Igf1 in lungs of prenatally smoke-exposed offspring at
thirty days after birth [11]. Given that parenchymal degenera-
tion of the liver after PSE has been described before [12], nega-
tively affected hepatic methylation and gene expression appear
to be likely, and a growing body of evidence suggests that ciga-
rette smoke may impact incidence, severity, and clinical course
of chronic liver diseases [13].
Insulin-like growth factors (IGFs) play an important role in
pre- and post-natal development in the mouse [14]. The binding
of IGF1 activates insulin-like growth factor 1 receptor (IGF1R),
which is coupled to important intracellular second messenger
pathways. In vivo knockout studies emphasized the function of
Igf1r, as its deletion alone or in combination with Igf1 caused
severe developmental restrictions with abnormalities in lung
development and immediate postnatal death [15–17].
Although few studies were attained in serum samples of
human neonates (e.g., [18]), the effect of prenatal smoke
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exposure on the IGFs and their receptors in different organs at
early developmental stages is very limited.
We hypothesized that the negative effect of prenatal smoke
exposure on DNA methylation and mRNA levels of Igf1r and
Igf1 at 30 days of age is also detectable at earlier stages, and that
these alterations are not only sex- but also organ-speciﬁc. To
test these hypotheses, lung and liver of prenatally smoke-
exposed fetal (E17.5) and three-day-old (D3) offspring were
collected for the assessment of promoter methylation patterns
as well as mRNA levels of Igf1r and Igf1. In a second step, we
aimed to compare the effect of prenatal smoke exposure in
female versus male offspring, followed by similar but sex-
dependent comparisons in lung versus liver. We continued this
study by comparing the obtained results from fetuses versus
neonates to evaluate if sex- and organ-dependent smoke-
induced alterations are affected during the ﬁrst days after birth.
These analyses were followed by nonparametric correlation
analyses to identify possible links between PSE-induced differ-
ential methylation status and mRNA levels. A link between the
two parameters would indicate biological relevance.
Results
PSE leads to sex-dependent hypomethylation at the Igf1r
promoter in lung but hypermethylation in the liver
Lung
General hypomethylation was detected in fetal lung at
eight CpG sites (CpG-255, P value = 0.03; CpG-246, P = 0.03;
CpG-233, P = 0.001; CpG-223, P = 0.02; CpG-215, P = 0.04;
CpG-209, P = 0.04; CpG-206, P = 0.004; CpG-201, P = 0.05; Sup-
plementary Figure 1A). No signiﬁcant changes were observed in
neonatal lung when both sexes were analyzed together (Supple-
mentary Figure 1).
Hypomethylation in fetal lung in female mice was observed
at nine CpG sites [CpG-272 (P = 0.04), CpG-255 (P = 0.02),
CpG-252 (P = 0.01), CpG-249 (P = 0.03), CpG-246 (P = 0.02),
CpG-238 (P = 0.04), CpG-233 (P = 0.01), CpG-223 (P = 0.04),
CpG-206 (P = 0.03); Supplementary Figure 2a], whereas
only two CpG sites were hypomethylated in males [CpG-215
(P = 0.05), CpG-206 (P = 0.01); Supplementary Figure 2A].
In neonatal lung, CpG-246 and CpG-166 were hypomethy-
lated in male offspring (P = 0.05 and P = 0.03, respectively;
Supplementary Figure 2B), whereas no differences were found
in female mice (Supplementary Figure 2b). Of note, male and
female neonates showed differential baseline methylation at
CpG-215 (P = 0.04), CpG-206 (P = 0.03), and CpG-166
(P = 0.03) after PSE (data not shown). Lung of fetal mice did
not show distinct baseline methylation but CpG-272 (P = 0.02),
CpG-252 (P = 0.01), and CpG-194 (P = 0.05) presented diver-
gent methylation status (data not shown).
Liver
Contrasting the observations in fetal lung, Igf1r in fetal liver
was hypermethylated at three CpG sites after PSE (CpG-215,
P = 0.05; CpG-206, P = 0.05; CpG-166, P = 0.04; Figure S1C).
In neonatal liver only CpG-17 was hypomethylated (P = 0.03;
Figure S1D).
Sex-dependent analysis of Igf1r promoter methylation in
fetal liver uncovered hypermethylation at CpG-194 (P = 0.05)
and CpG-166 (P = 0.04) as well as hypomethylation at CpG-17
(P = 0.01) in male fetuses (Supplementary Figure 2C), but no
effect in females (Supplementary Figure 2c).
While no signiﬁcant effects were seen in male and female
neonates (Supplementary Figure 2D, d), differential baseline
methylation was found for CpG-215 (P = 0.02) in neonates and
CpG-17 (P = 0.03) in fetuses. PSE caused a signiﬁcant differen-
tial response in male and female fetuses at CpG-252 (P = 0.04),
and CpG-230 (P = 0.03).
Organ-speciﬁc Igf1r promoter methylation signature is
abolished after PSE
The differential PSE response in lung and liver of both fetuses
and neonates prompted us to further compare the methylation
status per organ and per time point in a sex-dependent way.
Figure 1 depicts these comparisons.
E17.5 offspring
A total of 12 CpG sites was found with higher baseline methyla-
tion in lung than in liver in the group of male control offspring
(CpG-272, P = 0.02; CpG-255, P = 0.05; CpG-246, P = 0.03;
CpG-230, P = 0.03; CpG-215, P = 0.003; CpG-209, P = 0.04;
CpG-206, P = 0.003; CpG-194, P = 0.01; CpG-185, P = 0.003;
CpG-182, P = 0.007; CpG-166, P = 0.002; CpG-164, P = 0.03;
Figure 1A). Similarly, ﬁve CpG sites showed different baseline
methylation in lung and liver of female offspring (CpG-252,
P = 0.02; CpG-233, P = 0.05; CpG-209, P = 0.03; CpG-194,
P = 0.04; CpG-171, P = 0.04; Figure 1B).
These ﬁndings are contrasted by the analysis of Igf1r pro-
moter methylation in lung and liver after prenatal smoke expo-
sure. Here, the described differences in baseline methylation
were no longer found and organ-speciﬁc methylation was not
detected (Figure 1a, b).
D3 offspring
Similar to the ﬁndings in fetuses, a total of 10 CpG sites showed
higher baseline methylation in lung than in liver of male con-
trol offspring (CpG-252, P = 0.01; CpG-246, P = 0.04;
CpG-209, P = 0.02; CpG-206, P = 0.03; CpG-201, P = 0.005,
CpG-194, P = 0.02; CpG-185, P = 0.02; CpG-182, P = 0.009;
CpG-171, P = 0.005; CpG-166, P = 0.007; Figure 1C). CpG-252
was the only site with signiﬁcantly higher baseline methylation
in lung of female neonates when compared to their liver
(P = 0.03; Figure 1D).
Diverging from these observations, PSE induced higher
methylation status of seven CpG sites in lung when compared
to liver of female neonates (CpG-252, P = 0.01; CpG-215,
P = 0.03; CpG-206, P = 0.003; CpG-185, P = 0.02; CpG-171,
P = 0.003; CpG-166, P = 0.008; CpG-164, P = 0.01; Figure 1d).
Notably, in male neonates, only CpG-252 could still be seen
with signiﬁcantly higher methylation in lung than in liver after
prenatal smoke exposure (P = 0.02; Figure 1c).
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Status quo of natural Igf1rmethylation pattern is sex- and
organ-speciﬁcally disrupted by PSE
Following up on the described differences between lung and
liver, we asked if baseline methylation in both organs of male
and female offspring was constant throughout the experimental
time frame. Likewise, we examined if the PSE-induced altera-
tions at fetal age remained until postnatal day three. The results
are shown in Figure 2.
Lung
Higher baseline methylation was seen at CpG-233 in both male
(P = 0.02; Figure 2A) and female (P = 0.01; Figure 2B) fetuses
when compared to neonates. Moreover, methylation at CpG-
164 was signiﬁcantly increased in female neonates (P = 0.04;
Figure 2B).
After PSE, higher methylation of ﬁve CpG sites was found in
female neonates: CpG-215 (P = 0.04), CpG-206 (P = 0.008),
CpG-171 (P = 0.04), CpG-166 (P = 0.05), and CpG-164
(P = 0.03; Figure 2b), but male offspring appeared unaffected.
Liver
While no time point differences were found in male control
mice (Figure 2C), CpG-233 was found with higher baseline
methylation in female fetuses when compared to three-day-old
animals (P = 0.05; Figure 2D). These observations were
inverted in PSE mice. Here, three CpG sites were found with
higher methylation in male fetuses when compared to male
neonates (CpG-255, P = 0.05; CpG-252, P = 0.05; CpG-246,
P = 0.01; Figure 2c), while no signiﬁcant differences were
detected in female offspring (Figure 2d).
PSE leads to hypermethylation of the Igf1 promoter in
liver, but not in lung, and imposes a potentially heavier
burden on female offspring
Similar to the data obtained for Igf1r, we also conducted a com-
parative analysis of Igf1 promoter methylation in both organs
of male and female offspring.
While only one CpG site was detected with hypomethylation
after PSE in fetal lung (CpG-1341, P = 0.02; Supplementary
Figure 3A), and Igf1 promoter methylation in neonatal lung
appeared to be unaffected (Supplementary Figure 3B), PSE
effect on Igf1 methylation pattern in liver was inverted. Here,
hypermethylation was found at ﬁve CpG sites (CpG-1509,
P = 0.006; CpG-1465, P = 0.04; CpG-1430, P = 0.008; CpG-
1254, P<0.0001; CpG-1212, P = 0.04; Supplementary Figure
3C). Similarly, in neonatal liver, ﬁve CpG sites were hyperme-
thylated after PSE (CpG-1509, P = 0.002; CpG-1430, P = 0.01;
CpG-1357, P = 0.02; CpG-1254, P = 0.007; CpG-1212,
P = 0.01; Figure S3D). PSE-induced hypomethylation in fetal
lung was found only for female offspring at CpG-1341 (P = 0.006)
and CpG-1212 (P = 0.01; Figure S3a), while fetal lung of male off-
spring together with neonatal lung of both sexes appeared to be
unaffected by PSE (Supplementary Figure 4A, B, b).
Hypermethylation in fetal liver was mainly seen in male off-
spring at ﬁve CpG sites (CpG-1509, P = 0.02; CpG-1430,
P = 0.02; CpG-1254, P = 0.0004; CpG-1212, P = 0.02; and
CpG-1180, P = 0.02; Figure S4C); two of those sites were
retrieved in female offspring (CpG-1430, P = 0.05; CpG-1254,
P = 0.04; Supplementary Figure 4c). Moreover, differential
baseline methylation was found for CpG-1254 (P = 0.04).
Hypomethylation in neonatal liver was signiﬁcant in female
offspring at CpG-1509 (P = 0.02; Supplementary Figure 4d).
Figure 1. Sex-dependent organ comparison of Igf1r promoter methylation status per time point. (A-D) CpG site-speciﬁc comparison of Igfr1 promoter methylation in fetal
(A, B: n = 12 fetuses for each group) and neonatal (C, D) lung and liver of male (A, C: n = 11) and female (B, D: n = 12) control offspring. (a-d) CpG site speciﬁc comparison
of Igf1r promoter methylation in fetal (a, b: n = 12 fetuses for each group) and neonatal (c, d) lung and liver of male (a, c: n = 11) and female (b, d: n = 8) PSE offspring.
CpG site annotations are relative to ATG start codon. Data are presented per sex, organ, and group as mean § SEM. If not stated otherwise, the comparison of displayed
groups was not signiﬁcant. P values  0.05,  0.01 (Mann-Whitney U-test). Open symbols: control group, closed symbols: PSE group.
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Speciﬁcity of Igf1methylation pattern per sex, organ, and
time point is modiﬁed after PSE
When comparing the baseline methylation levels of lung and
liver in male and female offspring, organ-speciﬁc promoter
methylation patterns were found. Within these, sex-speciﬁc
variations were seen.
At fetal stage, methylation status at CpG-1465 (P = 0.03)
was signiﬁcantly different in female but not in male offspring
(Figure 3A, B). The remaining signiﬁcant organ-speciﬁc differ-
ential methylation at CpG-1509, CpG-1357, CpG-1254, CpG-
1212, and CpG-1180 was detectable in both male and female
offspring (all P<0.0001, except CpG-1180, female: P = 0.001,
male: P = 0.05).
At neonatal stage, sex differences were found for CpG-1456
(P = 0.01), CpG-1341 (P = 0.008), and CpG-1180 (P = 0.003)
in male (Figure 3C) and CpG-1357 (P = 0.03) in female
offspring (Figure 3D). The remaining signiﬁcant organ-
speciﬁc differential methylation at CpG-1509 (male/female:
P = 0.001/0.0009), CpG-1430 (male/female: P = 0.01/0.003)
and CpG-1254 (male/female: P0.0001/0.0006) was detectable
for both male and female offspring.
In light of these observations, it is extremely interesting that
PSE disrupts the described sex-speciﬁc differences at both time
points. Differential methylation in fetal female offspring at
CpG-1465 and CpG-1254 was lost after PSE. This caused loss
of sex-differences at CpG-1465 and induction at CpG-1254, as
in male fetuses differential methylation status, remained after
PSE (Figure 3a, b). Notably, methylation status of CpG-1430 in
organ comparison of males and females is now signiﬁcantly
different (male/female, P = 0.002/0.006) and at CpG-1180
more pronounced (P = 0.002) in male fetuses.
Differential baseline methylation status at CpG-1465 in male
neonates was lost after PSE but induced at CpG-1357
(P = 0.002), which, in both cases, caused loss of sex-differences
in organ comparison. Similarly, also in female neonates, sex-
differences were lost after PSE-induced differential organ-spe-
ciﬁc methylation at CpG-1341 (P = 0.02) and CpG-1180
(P = 0.0007; Figure 3c,d). The signiﬁcant organ differences
found at other CpG sites remained unaffected by PSE (CpG-
1509, male/female: P0.0001/0.0005; CpG-1430, male/female:
P = 0.004/<0.0001; CpG-1357, female: P = 0.02; CpG-1341,
male: P = 0.01; CpG-1254, male/female: P = 0.007/0.0002;
CpG-1180,male: P = 0.003).
Similar to the ﬁndings from the organ comparison experi-
ment, the time point comparison also revealed a naturally
established but sex-dependent change in methylation at the
Igf1 promoter. These patterns are disrupted after PSE and
Figure 4 presents an overview.
Baseline methylation in lung of male offspring shows time
point differences at four CpG sites (CpG-1509, P = 0.05; CpG-
1465, P = 0.03; CpG-1430, P = 0.01; CpG-1212, P = 0.05;
Figure 4A), of which only one could be retrieved in female
mice (CpG-1465, P = 0.02; Figure 4B). PSE caused loss of time
point differences in male mice at CpG-1509 and CpG-1212,
but the remaining two sites were unaffected (CpG-1465,
P = 0.05; CpG-1430, P = 0.03; Figure 4a). This is contrasted by
the induction of time point differences in female offspring at
CpG-1430 (P = 0.0008) and enhanced differential methylation
at CpG-1465 (P = 0.01; Figure 4b).
Figure 2. Sex-dependent time point comparison of Igf1r promoter methylation status in lung and liver. (A-D) CpG site-speciﬁc comparison of Igf1r promoter methylation
per time point in lung (A, B) and liver (C, D) of male (A, C) and female (B, D) control offspring (n = 12 for each fetal group; neonates: n = 11 male, n = 8 female). (a-d) CpG
site-speciﬁc comparison of Igf1 promoter methylation per time point in lung (a, b) and liver (c, d) of male (a, c) and female (c, d) PSE offspring (n = 12 for each group; neo-
nates: n = 11 males, n = 12 females). CpG site annotations are relative to ATG start codon. Data are presented per sex, organ, and group as mean§ SEM. If not stated oth-
erwise, the comparison of displayed groups was not signiﬁcant. P values:  0.05,  0.01 (Mann-Whitney U-test). Open symbols: control group, closed symbols: PSE
group.
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Figure 3. Sex-dependent organ comparison of Igf1 promoter methylation status per time point. (A-D) CpG site-speciﬁc comparison of Igf1 promoter methylation in fetal
(A, B; n = 12 fetuses for each group) and neonatal (C, D) lung and liver of male (A, C: n = 11) and female (B, D: n = 12) control offspring. (a-d) CpG site-speciﬁc comparison
of Igf1 promoter methylation in fetal (a, b: n = 12 fetuses for each group) and neonatal (c, d) lungs and liver of male (a, c: n = 11) and female (b, d: n = 8) PSE offspring.
CpG site annotations are relative to ATG start codon. Data are presented per sex, organ, and group as mean § SEM. If not stated otherwise, the comparison of displayed
groups was not signiﬁcant. P values:  0.05,  0.01,  0.001,  0.0001 (Mann-Whitney U-test). Open symbols: control group, closed symbols: PSE group.
1080 K. F. MEYER ET AL.
Figure 4. Sex-dependent time point comparison of Igf1 promoter methylation status per time point. (A-D) CpG site-speciﬁc comparison of Igf1 promoter methylation per
time point in lung (A, B) and liver (C, D) of male (A, C) and female (B, D) control groups (n = 12 for each fetal group; neonates: n = 11 male, n = 8 female). (a-d) CpG site-
speciﬁc comparison of Igf1 promoter methylation per time point in lung (a, b) and liver (c, d) of male (a, c) and female (c, d) PSE groups (n = 12 for each group; neonates:
n = 11 males, n = 12 females). CpG site annotations are relative to ATG start codon. Data are presented per sex, organ, and group as mean§ SEM. If not stated otherwise,
the comparison of displayed groups was not signiﬁcant. P values:  0.05,  0.01,  0.001,  0.0001 (Mann-Whitney U-test). Open symbols: control group,
closed symbols: PSE group.
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Table 1. Correlation between Igf1r mRNA concentration and Igf1r promoter methylation in fetal and neonatal lung
E17.5 lung
Correlation of / with Igf1r (2¡DCT) All All male All female All control All PSE Male control Male PSE Female control Female PSE
Igf1r promoter
methylation [%]
CG-272 r -0.07 -0.53 -0.02 -0.02 -0.08 -0.11 -0.88 -0.01 0.29
P value ns <0.05 ns ns ns ns <0.001 ns ns
CG-255 r -0.20 -0.30 -0.23 -0.15 -0.08 -0.23 -0.45 -0.11 0.02
P value ns ns ns ns ns ns ns ns ns
CG-252 r -0.21 -0.45 -0.15 -0.20 -0.07 -0.36 -0.66 -0.07 0.17
P value ns <0.05 ns ns ns ns <0.05 ns ns
CG-249 r -0.09 -0.10 -0.11 -0.04 0.07 0.16 -0.46 -0.10 0.32
P value ns ns ns ns ns ns ns ns ns
CG-246 r -0.13 -0.28 -0.07 -0.10 0.00 -0.08 -0.65 -0.21 0.20
P value ns ns ns ns ns ns <0.05 ns ns
CG-238 r -0.18 -0.11 -0.23 -0.09 -0.20 0.15 -0.38 -0.21 0.03
P value ns ns ns ns ns ns ns ns ns
CG-233 r -0.18 -0.16 -0.19 -0.17 0.09 0.02 -0.23 -0.29 0.38
P value ns ns ns ns ns ns ns ns ns
CG-230 r -0.11 -0.06 -0.14 -0.11 0.04 0.21 -0.44 -0.21 0.30
P value ns ns ns ns ns ns ns ns ns
CG-228 r -0.09 -0.01 -0.11 -0.12 0.12 0.21 -0.19 -0.20 0.41
P value ns ns ns ns ns ns ns ns ns
CG-223 r -0.05 -0.45 0.19 -0.18 0.12 -0.19 -0.62 -0.03 0.52
P value ns <0.05 ns ns ns ns <0.05 ns ns
CG-215 r -0.20 -0.32 -0.10 0.29 -0.46 0.06 -0.48 0.58 -0.37
P value ns ns ns ns <0.05 ns ns ns ns
CG-209 r -0.09 -0.25 -0.05 -0.09 0.09 -0.33 -0.02 0.03 0.11
P value ns ns ns ns ns ns ns ns ns
CG-206 r -0.12 -0.26 -0.12 -0.10 0.09 -0.14 -0.31 -0.24 0.21
P value ns ns ns ns ns ns ns ns ns
CG-201 r -0.05 -0.18 -0.02 -0.07 0.10 -0.14 -0.12 -0.10 0.21
P value ns ns ns ns ns ns ns ns ns
CG-194 r -0.02 -0.29 0.08 -0.07 0.11 -0.32 -0.21 -0.03 0.25
P value ns ns ns ns ns ns ns ns ns
CG-185 r -0.01 -0.12 -0.05 0.06 0.10 -0.19 0.17 0.09 0.04
P value ns ns ns ns ns ns ns ns ns
CG-182 r -0.09 -0.09 0.15 -0.06 0.25 -0.07 -0.04 -0.33 0.41
P value ns ns ns ns ns ns ns ns ns
CG-171 r -0.16 -0.24 -0.18 -0.24 0.10 -0.23 -0.29 -0.45 0.31
P value ns ns ns ns ns ns ns ns ns
CG-166 r -0.21 -0.32 -0.21 -0.19 -0.03 -0.26 -0.23 -0.22 0.01
P value ns ns ns ns ns ns ns ns ns
CG-164 r -0.05 -0.23 0.01 -0.11 0.07 -0.45 -0.07 0.09 0.10
P value ns ns ns ns ns ns ns ns ns
CG-17 r -0.19 -0.24 -0.20 -0.08 -0.27 -0.04 -036 -0.15 -0.24
P value ns ns ns ns ns ns ns ns ns
Correlation of / with Igf1r (2¡DCT) D3 lung
All All male All female All control All PSE Male control Male PSE Female control Female PSE
Igf1r promoter
methylation [%]
CG-272 r 0.08 0.28 -0.13 -0.23 0.27 -0.05 0.69 -0.51 0.03
P value ns ns ns ns ns ns <0.05 ns ns
CG-255 r 0.08 0.22 -0.22 -0.24 0.28 -0.02 0.41 -0.65 0.20
P value ns ns ns ns ns ns ns ns ns
CG-252 r 0.12 0.30 -0.10 -0.35 0.40 -0.11 0.80 -0.76 0.17
P value ns ns ns ns ns ns <0.01 ns ns
CG-249 r 0.02 0.32 -0.30 -0.40 0.32 -0.08 0.64 -0.81 0.02
P value ns ns ns ns ns ns <0.05 ns ns
CG-246 r 0.23 0.62 -0.15 0.37 0.20 0.70 0.64 -0.37 -0.07
P value ns <0.001 ns ns ns <0.05 <0.05 ns ns
CG-238 r -0.08 0.09 -0.23 -0.42 0.17 -0.01 0.25 -0.89 0.13
P value ns ns ns ns ns ns ns <0.01 ns
CG-233 r 0.00 0.03 -0.02 -0.35 0.25 -0.27 0.46 -0.50 0.17
P value ns ns ns ns ns ns ns ns ns
CG-230 r 0.03 0.17 -0.19 -0.31 0.31 -0.11 0.56 -0.80 0.13
P value ns ns ns ns ns ns ns ns ns
CG-228 r 0.17 0.26 0.04 -0.19 0.47 0.07 0.56 -0.88 0.40
P value ns ns ns ns <0.05 ns ns <0.01 ns
CG-223 r 0.17 0.31 -0.06 -0.23 0.47 0.04 0.63 -0.86 0.34
P value ns ns ns ns <0.05 ns <0.05 <0.05 ns
CG-215 r -0.12 0.05 -0.30 0.01 -0.22 -0.06 0.02 0.02 -0.41
P value ns ns ns ns ns ns ns ns ns
CG-209 r 0.08 0.12 0.05 -0.24 0.24 -0.02 0.12 -0.67 0.31
P value ns ns ns ns ns ns ns ns ns
CG-206 r -0.20 -0.09 -0.39 -0.23 -0.25 -0.15 -0.27 -0.72 -0.28
P value ns ns 0.08 ns ns ns ns ns ns
CG-201 r -0.15 -0.22 -0.06 0.17 -0.44 0.25 -0.72 0.05 -0.20
P value ns ns ns ns <0.05 ns <0.05 ns ns
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Differential baseline methylation at CpG-1509 (P = 0.05),
CpG-1465 (P = 0.04), and CpG-1430 (P = 0.004) was observed
when comparing fetal and neonatal liver from male offspring
(Figure 4C). While CpG-1509 (P = 0.03) and CpG-1430 (P =
0.0002) were also found in females, CpG-1465 was not, and
CpG-1357 (P = 0.04; Figure 4D) was observed instead. In con-
trast to the observations in male lung, PSE induced differential
methylation at CpG-1357 (P = 0.05) and CpG-1254 (P = 0.03;
Figure 4c) in male liver, whereas time point differences in
female was lost at CpG-1509 but induced at CpG-1254
(P = 0.02), CpG-1212 (P = 0.05), and CpG-1180 (P = 0.04;
Figure 4d).
What is the (biological) relevance of the PSE-induced
change of Igf1r and Igf1 promoter methylation?
In addition to the observed drift in promoter methylation pat-
terns of Igf1r and Igf1, we sought to determine the biological
relevance of the described changes. DNA methylation is one of
several epigenetic modiﬁcations that may inﬂuence/affect the
complex process of gene transcription, which involves several
regulatory steps. We therefore considered the presence (or
absence) of correlation between promoter methylation and
mRNA levels of our target genes as a surrogate of a possible
link.
Igf1r
Within all analyzed offspring, we found a negative correlation
between Igf1r CpG-215 methylation status and Igf1r mRNA
levels in fetal lung after PSE (r = 0.46, P<0.05; Table 1). More-
over, PSE induced correlations at CpG-272 (r = ¡0.88,
P<0.001), CpG-252 (r = ¡0.66, P<0.05), CpG-246 (r = ¡0.65,
P<0.05), and CpG-223 (r = 0.62, P<0.05; Table 1) in the lung
of male, but not of female, fetuses.
A sex-independent correlation was found for CpG-228
(r = 0.47, P<0.05), CpG-223 (r = 0.47, P<0.05), and CpG-201
(r = ¡0.44, P<0.05; Table 1) after PSE in neonatal lung,
whereas a sex-dependent discrimination of subgroups revealed
associations at CpG-246 (r = 0.74, P<0.01) in male control
mice and at CpG-272 (r = 0.69, P<0.05), CpG-252 (r = 0.80,
P<0.01), CpG-249 (r = 0.64, P<0.05), CpG-246 (r = 0.64,
P<0.05), CpG-223 (r = 0.63, P<0.05), and CpG-201 (r =
¡0.72, P<0.05; Table 1) in male PSE offspring. Taking both
male subgroups together, methylation at CpG-246 and Igf1r
mRNA levels in neonatal lung correlated strongly (r = 0.62,
P<0.001; Table 1).
These observations are contrasted by the ﬁndings in lung of
female neonates. Here, inverse correlations were seen exclu-
sively in control mice for CpG-238 (r = ¡0.89, P<0.01), CpG-
228 (r = ¡0.88, P<0.01), and CpG-223 (r = ¡0.86, P<0.05;
Table 1), which were disrupted after PSE. The described oppo-
site correlations (positive vs. inverse) in male and female may
offset each other and hence may result in a lack of general
correlations.
In fetal liver, correlation was seen for CpG-17 in female off-
spring (r = 0.52, P<0.05; Table 2). Moreover, a sex-indepen-
dent correlation was found after PSE at CpG-17 (r = 0.48,
P<0.05; Table 2). The PSE-induced effect was only seen in
male offspring, as four CpG sites were found with correlations
after PSE CpG-233 (r = 0.64, P<0.05), CpG-215 (r = 0.74,
P<0.01), CpG-209 (r = 0.82, P0.01), and CpG-185 (r = 0.62,
P0.05; Table 2).
Igf1
In fetal lung, PSE-induced correlation was found only at CpG-
1180 (r = 0.51, P<0.05; Table 3) in male and female neonates.
Instead, in neonatal lung, PSE induced correlation at CpG-
1254 (r = 0.68, P<0.05; Table 3) in males only, whereas an
inverse correlation after PSE was found in females at CpG-
1212 (r = 0.68, P<0.05; Table 3). The correlation between
methylation at CpG-1341 and Igf1 mRNA levels appeared to be
sex-dependent: male control offspring showed positive correla-
tion (r = 0.67, P<0.05) but female controls showed inverse cor-
relation (r = ¡0.73, P<0.05; Table 3).
A general correlation between Igf1 mRNA levels and meth-
ylation was seen in fetal liver at CpG-1509 (r = ¡0.34, P<0.05)
and CpG-1430 (r = ¡0.39, P<0.05), which was also found in
control mice (r = ¡0.55, P<0.05) but was disrupted after PSE.
Sex-dependent correlations at CpG-1509 (r = ¡0.47, P<0.05),
CpG-1430 (r = ¡0.59, P<0.05), and CpG-1254 (r = ¡0.47,
P0.05) were seen in male but not in female mice.
Correlations in neonatal liver were found in all offspring for
CpG-1430 (r = ¡0.60, P0.001), CpG-1254 (r = ¡0.80,
P<0.0001), CpG-1212 (r = ¡0.52, P<0.01), and CpG-1180
(r = ¡0.52, P<0.001; Table 3). All of these were also detected
when discriminating between male and female mice. While the
Table 1. (Continued )
E17.5 lung
Correlation of / with Igf1r (2¡DCT) All All male All female All control All PSE Male control Male PSE Female control Female PSE
CG-194 r -0.21 -0.23 -0.19 -0.22 -0.32 -0.07 -0.54 -0.49 -0.11
P value ns ns ns ns ns ns ns ns ns
CG-185 r -0.04 -0.07 -0.01 -0.18 0.00 -0.13 -0.20 -0.34 0.14
P value ns ns ns ns ns ns ns ns ns
CG-182 r -0.21 -0.17 -0.35 -0.13 -0.36 -0.06 -0.55 -0.57 -0.23
P value ns ns ns ns ns ns ns ns ns
CG-171 r -0.02 -0.01 -0.09 -0.06 -0.07 0.10 -0.26 -0.60 0.11
P value ns ns ns ns ns ns ns ns ns
CG-166 r 0.07 0.11 -0.06 -0.13 0.13 -0.05 0.04 -0.53 0.27
P value ns ns ns ns ns ns ns ns ns
CG-164 r -0.21 -0.20 -0.27 -0.24 -0.27 -0.09 -0.54 -0.78 0.07
P value ns ns ns ns ns ns ns ns ns
CG-17 r -0.01 -0.12 0.34 -0.08 -0.20 -0.23 -0.01 0.54 -0.33
P value ns ns ns ns ns ns ns ns ns
ns: non signiﬁcant
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Table 2. Correlation between Igf1r mRNA concentration and Igf1r promoter methylation in fetal and neonatal liver
Correlation of / with Igf1r (2¡DCT) E17.5 liver
All All male All female All control All PSE Male control Male PSE Female control Female PSE
Igf1r promoter methylation [%] CG-272 r -0.10 -0.05 0.05 -0.12 0.17 0.03 0.59 0.24 0.07
P value ns ns ns ns ns ns ns ns ns
CG-255 r 0.25 0.11 0.17 0.23 0.22 0.46 0.57 0.16 0.14
P value ns ns ns ns ns ns ns ns ns
CG-252 r 0.26 0.01 0.25 0.27 0.10 0.35 0.49 0.27 0.16
P value ns ns ns ns ns ns ns ns ns
CG-249 r 0.04 0.07 -0.03 0.06 0.11 0.11 0.41 -0.06 0.02
P value ns ns ns ns ns ns ns ns ns
CG-246 r 0.08 0.04 0.12 0.11 0.22 0.18 0.54 0.10 0.08
P value ns ns ns ns ns ns ns ns ns
CG-238 r 0.10 0.05 0.15 0.03 0.27 -0.10 0.43 0.12 0.33
P value ns ns ns ns ns ns ns ns ns
CG-233 r 0.29 0.32 0.24 0.28 0.36 0.27 0.64 0.32 0.09
P value ns ns ns ns ns ns <0.05 ns ns
CG-230 r 0.02 0.05 -0.07 0.02 0.08 0.03 0.48 -0.09 -0.09
P value ns ns ns ns ns ns ns ns ns
CG-228 r -0.16 -0.17 -0.14 -0.20 -0.06 -0.16 0.09 -0.13 -0.05
P value ns ns ns ns ns ns ns ns ns
CG-223 r 0.12 0.08 0.18 0.14 0.13 0.25 0.16 0.12 0.54
P value ns ns ns ns ns ns ns ns ns
CG-215 r 0.03 -0.11 0.17 -0.03 0.28 -0.18 0.74 0.26 0.08
P value ns ns ns ns ns ns <0.01 ns ns
CG-209 r -0.09 -0.32 0.27 -0.21 0.35 -0.42 0.82 0.29 0.26
P value ns ns ns ns ns ns <0.01 ns ns
CG-206 r -0.06 -0.08 -0.03 -0.18 0.25 -0.13 0.38 -0.10 -0.04
P value ns ns ns ns ns ns ns ns ns
CG-201 r 0.27 0.32 0.14 0.20 0.22 0.41 0.47 0.08 0.40
P value ns ns ns ns ns ns ns ns ns
CG-194 r -0.04 -0.20 0.18 -0.12 0.28 -0.10 0.41 0.06 0.40
P value ns ns ns ns ns ns ns ns ns
CG-185 r -0.06 -0.08 0.00 -0.08 0.15 -0.06 0.62 0.11 -0.41
P value ns ns ns ns ns ns <0.05 ns ns
CG-182 r 0.01 0.06 -0.01 -0.12 0.26 0.04 0.40 -0.05 0.16
P value ns ns ns ns ns ns ns ns ns
CG-171 r -0.04 -0.08 0.02 -0.20 0.37 -0.09 0.38 -0.19 0.47
P value ns ns ns ns ns ns ns ns ns
CG-166 r -0.01 -0.17 0.20 -0.12 0.38 -0.14 0.50 0.07 0.46
P value ns ns ns ns ns ns ns ns ns
CG-164 r -0.06 0.14 -0.17 -0.15 0.19 0.11 0.45 -0.17 -0.14
P value ns ns ns ns ns ns ns ns ns
CG-17 r 0.33 0.17 0.52 0.24 0.48 -0.26 0.20 0.50 0.43
P value ns ns <0.05 ns <0.05 ns ns ns ns
Correlation of / with Igf1r (2¡DCT) D3 liver
all all male all female all control all PSE male control male PSE female control female PSE
Igf1r promoter methylation [%] CG-272 r 0.05 0.01 0.12 0.18 0.42 -0.20 0.32 0.51 0.36
P value ns ns ns ns ns ns ns ns ns
CG-255 r 0.08 0.01 0.30 0.25 0.18 -0.13 0.08 0.61 0.40
P value ns ns ns ns ns ns ns ns ns
CG-252 r 0.07 -0.02 0.20 0.00 0.28 -0.34 0.20 0.39 0.44
P value ns ns ns ns ns ns ns ns ns
CG-249 r -0.01 -0.01 -0.02 0.02 0.24 -0.19 0.23 0.26 0.23
P value ns ns ns ns ns ns ns ns ns
CG-246 r 0.17 0.10 0.26 0.11 0.36 -0.28 0.37 0.50 0.29
P value ns ns ns ns ns ns ns ns ns
CG-238 r 0.08 0.09 0.08 0.25 0.12 -0.13 0.28 0.63 -0.10
P value ns ns ns ns ns ns ns ns ns
CG-233 r -0.13 -0.32 0.12 -0.12 0.02 -0.68 -0.33 0.52 0.22
P value ns ns ns ns ns <0.05 ns ns ns
CG-230 r -0.08 -0.07 -0.10 -0.14 0.23 -0.45 0.32 0.35 0.03
P value ns ns ns ns ns ns ns ns ns
CG-228 r -0.21 -0.31 -0.03 -0.23 0.09 -0.59 0.12 0.32 0.14
P value ns ns ns ns ns ns ns ns ns
CG-223 r -0.17 -0.26 -0.13 -0.10 0.10 -0.25 0.02 0.12 0.10
P value ns ns ns ns ns ns ns ns ns
CG-215 r 0.08 -0.23 0.49 -0.07 0.08 -0.37 -0.06 0.46 0.21
P value ns ns <0.05 ns ns ns ns ns ns
CG-209 r -0.16 -0.32 -0.15 0.05 -0.12 -0.38 -0.05 0.61 -0.25
P value ns ns ns ns ns ns ns ns ns
CG-206 r -0.09 -0.15 -0.01 -0.13 -0.06 -0.14 0.19 0.48 -0.30
P value ns ns ns ns ns ns ns ns ns
CG-201 r -0.07 -0.11 -0.01 -0.27 0.21 -0.55 0.40 0.18 0.00
P value ns ns ns ns ns ns ns ns ns
CG-194 r -0.21 -0.38 0.08 0.09 -0.20 -0.05 -0.22 0.42 -0.13
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correlation for CpG-1254 was strongest and found within both
exposure groups, correlations for CpG-1430 (r = ¡0.55,
P<0.01; Table 3) and CpG-1180 (r = ¡0.52, P<0.05; Table 3)
were found sex-independently in control but not in PSE
groups.
Moderate PSE-effect on Igf1r and Igf1 gene expression
Hepatic mRNA levels of Igf1r and Igf1 were sex-dependently
affected at fetal stage (Igf1r, male: P = 0.01, female: P value non
signiﬁcant; Supplementary Figure 5D, Igf1, male, P = 0.04,
female, P value non signiﬁcant; Supplementary Figure 5M).
Here, Igf1r mRNA levels also showed differential PSE response
(P = 0.01; Supplementary Figure 5D) in male and female fetuses
and reduced gene expression at three days after birth (male:
P = 0.01, female: P = 0.03; Supplementary Figure 5E). A general
smoke effect was found for Igf1r mRNA in fetal lung (P = 0.03;
Supplementary Figure 5I), while no effect was seen in neonatal
lung.
In neonatal liver, the Igf1 mRNA levels were decreased in
PSE males and females (P = 0.08 in each group; Supplementary
Figure 5N), which resulted in a general and sex-independent
reduction (P = 0.01; Supplementary Figure 5R).
Divergent mRNA expression levels of Igf1r and Igf1 were
higher in lung when compared to liver (Igf1r: Supplementary
Figure 5G, H; Igf1: Supplementary Figure 5P,Q). Noteworthy
in this context are the higher mRNA levels of Igf1r and Igf1 in
fetal and neonatal lung when compared to liver as well as the
increase of Igf1 expression in liver when comparing fetuses and
neonates (Supplementary Figure 5O), together with a constant/
stable Igf1 expression in lung Supplementary Figure 5L).
Igf1r and Igf1 gene expression correlate in lung and liver
of fetuses and neonates
Expression levels of Igf1r and Igf1 correlated strongly in lung
and liver of both fetuses and neonates. A summary of the corre-
lation analysis per time point and organ can be found in
Table 4. For the lung, PSE did not have a large effect on the cor-
relation of Igf1 and Igf1r. However, for the liver, the discrimina-
tion upon sex and exposure type revealed a sex-dependent
effect of PSE on the Igf1r-Igf1 relation. While the correlation in
liver of male (r = 0.92, P<0.0001) and female (r = 0.82,
P0.01) fetuses, as well as female neonates (r = 0.83, P<0.05),
was disrupted after PSE, the opposite occurred in male neonatal
liver, where PSE induced a strong correlation (r = 0.91,
P<0.001), which was not present in male control neonates.
Discussion
Global methylation changes due to prenatal smoke exposure
(PSE) were described and, by now, validated in human infant
blood samples (e.g., [7]), but analysis in organs such as lung or
liver has been rarely done. As yet, it was concluded that epige-
netic responses to environmental in utero exposures are tissue-
speciﬁc [19], and that each tissue has a unique epigenetic signa-
ture that likely reﬂects differential tissue functions [20]. In the
present study, we described organ-speciﬁc rather than general
systemic fetal programming of Igf1r and Igf1 as a result of PSE,
which additionally caused sex-dependent and CpG site-speciﬁc
aberrant promoter methylation patterns. Sexually dimorphic
methylation patterns of several gene promoters were described
in the liver of male and female mice [21,22] and sex differences
in male mice were conserved during aging, while sex differences
in females were lost [23]. Moreover, the inﬂuence of, for exam-
ple nanoparticles or maternal dietary content (methyl donor
rich vs. poor) on gene promoter methylation in lung of mouse
offspring was previously demonstrated [24,25], but no other
studies analyzed the effect of PSE on methylation patterns of
our target genes in murine lung and liver at two time points.
The comparison of fetal and neonatal methylation patterns
revealed differences that highlight the severity of PSE. We can
relate the described alterations in organ-speciﬁc methylation
signatures of Igf1r and Igf1 in male and female mice to an addi-
tional smoking of 20 cigarettes. This may suggest that late-term
PSE can still induce fetal programming. This effect was pre-
dominantly seen for Igf1r in female lung and for Igf1 in female
liver.
We also found organ-speciﬁc Igf1r and Igf1 gene expression
with higher levels in lung than in liver. This indicates their
organ-speciﬁc production and suggests local regulation. Our
ﬁndings are in accordance with those that found that deletion
of hepatic Igf1 in mice leaves its local production in other tis-
sues unaffected [26]. When comparing fetuses and neonates,
we observed an increase of hepatic Igf1 expression accompa-
nied by simultaneous increase of Igf1r. Together with the stable
amount of Igf1 in lung, this may indicate the onset of a hepatic
secretory function, as Igf1 gene expression was shown to
Table 2. (Continued )
Correlation of / with Igf1r (2¡DCT) E17.5 liver
All All male All female All control All PSE Male control Male PSE Female control Female PSE
P value ns ns ns ns ns ns ns ns ns
CG-185 r 0.11 -0.10 0.41 0.08 0.20 -0.26 0.20 0.74 0.23
P value ns ns ns ns ns ns ns ns ns
CG-182 r 0.13 -0.05 0.36 0.28 0.32 0.05 0.20 0.66 0.52
P value ns ns ns ns ns ns ns ns ns
CG-171 r -0.14 -0.28 -0.08 0.12 -0.17 -0.12 -0.04 0.50 -0.26
P value ns ns ns ns ns ns ns ns ns
CG-166 r -0.01 -0.07 0.09 0.12 0.02 -0.10 0.11 0.50 -0.12
P value ns ns ns ns ns ns ns ns ns
CG-164 r 0.11 0.11 0.12 0.21 0.19 -0.02 0.30 0.60 -0.05
P value ns ns ns ns ns ns ns ns ns
CG-17 r 0.14 0.17 0.11 -0.14 -0.05 0.07 -0.21 -0.30 0.17
P value ns ns ns ns ns ns ns ns ns
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Table 3. Correlation between Igf1 mRNA concentration and Igf1 promoter methylation in fetal and neonatal lung and liver
Correlation of / with Igf1 (2¡DCT) E17.5 lung
All All male All
female
All
control
All PSE Male
control
Male
PSE
Female
control
Female
PSE
Igf1 promoter methylation
[%]
CG-1509 r 0.03 -0.04 0.07 0.07 -0.03 0.04 -0.09 0.07 0.03
P
value
ns ns ns ns ns ns ns ns ns
CG-1465 r -0.06 0.17 -0.33 -0.24 0.10 0.05 0.20 -0.25 -0.33
P
value
ns ns ns ns ns ns ns ns ns
CG-1430 r 0.07 0.01 0.13 0.06 0.06 0.30 -0.13 0.13 0.22
P
value
ns ns ns ns ns ns ns ns ns
CG-1357 r -0.03 0.17 -0.08 -0.27 0.19 -0.19 0.31 -0.18 0.12
P
value
ns ns ns ns ns ns ns ns ns
CG-1341 r -0.04 0.05 -0.13 -0.06 -0.01 0.00 0.03 0.04 -0.14
P
value
ns ns ns ns ns ns ns ns ns
CG-1254 r 0.03 0.25 -0.30 -0.25 0.16 0.20 0.28 -0.40 0.02
P
value
ns ns ns ns ns ns ns ns ns
CG-1212 r 0.01 0.38 -0.34 -0.32 0.32 0.30 0.44 -0.23 0.07
P
value
ns ns ns ns ns ns ns ns ns
CG-1180 r -0.03 0.21 -0.19 -0.41 0.51 -0.25 0.52 -0.51 0.31
P
value
ns ns ns ns <0.05 ns ns ns ns
Correlation of / with Igf1
(2¡DCT)
D3 lung
All All male All
female
All
control
All PSE Male
control
Male
PSE
Female
control
Female
PSE
Igf1 promoter methylation
[%]
CG-1509 r 0.09 0.01 0.19 0.14 0.21 0.21 0.05 -0.30 0.40
P
value
ns ns ns ns ns ns ns ns ns
CG-1465 r -0.10 0.21 -0.34 -0.23 -0.07 0.10 0.31 -0.52 -0.31
P
value
ns ns ns ns ns ns ns ns ns
CG-1430 r 0.14 0.35 -0.09 0.30 0.02 0.36 0.34 0.53 -0.35
P
value
ns ns ns ns ns ns ns ns ns
CG-1357 r -0.02 0.04 -0.09 -0.06 0.12 0.06 -0.15 -0.19 0.11
P
value
ns ns ns ns ns ns ns ns ns
CG-1341 r -0.06 0.52 -0.47 0.02 -0.35 0.67 -0.26 -0.73 -0.44
P
value
ns ns <0.05 ns ns <0.05 ns <0.05 ns
CG-1254 r 0.21 0.37 0.12 0.14 0.39 0.27 0.68 0.12 0.23
P
value
ns ns ns ns ns ns <0.05 ns ns
CG-1212 r -0.16 -0.11 -0.34 0.14 -0.36 0.07 -0.21 0.10 -0.68
P
value
ns ns ns ns ns ns ns ns <0.05
CG-1180 r -0.06 0.01 -0.14 0.40 -0.44 0.50 -0.32 0.40 -0.39
P
value
ns ns ns ns <0.05 ns ns ns ns
Correlation of / with Igf1
(2¡DCT)
E17.5 liver
All All male All
female
All
control
All PSE Male
control
Male
PSE
Female
control
Female
PSE
Igf1 promoter methylation
[%]
CG-1509 r -0.34 -0.47 -0.02 -0.32 -0.05 -0.28 -0.35 -0.29 0.14
P
value
<0.05 <0.05 ns ns ns ns ns ns ns
CG-1465 r -0.01 -0.14 0.15 0.01 0.04 -0.07 -0.30 0.08 0.16
P
value
ns ns ns ns ns ns ns ns ns
CG-1430 r -0.39 -0.59 -0.12 -0.55 -0.16 -0.41 -0.49 -0.51 0.24
P
value
<0.05 <0.05 ns <0.001 ns ns ns ns ns
CG-1357 r 0.02 -0.15 0.34 -0.19 0.35 -0.39 0.45 0.29 0.49
P
value
ns ns ns ns ns ns ns ns ns
CG-1341 r 0.04 -0.09 0.25 -0.20 0.35 -0.29 0.46 0.06 0.45
P
value
ns ns ns ns ns ns ns ns ns
CG-1254 r -0.17 -0.47 0.16 -0.38 0.28 -0.14 -0.32 -0.44 0.51
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gradually increase from fetal day 18 onwards [27] to postnatal
age [26], thus establishing its role in postnatal development.
PSE seems to interfere with these observations, considering the
reduced Igf1 mRNA levels in neonatal lung.
We also showed that PSE affects gene expression primarily
in male offspring. The predominant impact was observed in
liver. Various in vivo studies on organ-speciﬁc Igf1 gene expres-
sion showed its dependence on steroid hormone actions (e.g.,
[28,29]). Sexually dimorphic responses to PSE were described
in human fetal liver and suggest that, dependent on sex, differ-
ent pathways may be affected but may converge in the same
disease outcome [30,31]. Interestingly, sex-speciﬁc methylation
patterns were also affected by testosterone in selected organs,
which in turn inﬂuenced gene expression [32]. These ﬁndings
match our observation of higher baseline Igf1 gene expression
in lung of male fetuses for the reasons discussed above. Albeit
the moderate effect of PSE on Igf1r and Igf1 gene expression,
strong correlations in both organs suggest a mutual regulation.
Igf1 mediates its effects by exclusively interacting with Igf1r
[14], which suggests a feedback loop [33] in lung and liver at
both analyzed time points. A high susceptibility to smoke-
induced deregulation appears reasonable and is suggested by
the disturbance of the described correlations by PSE.
Until now, no technique is available to evaluate the extent of
how changes in mRNA levels are related to, inﬂuenced, or
maybe even caused by aberrant methylation of a gene promoter
under physiological circumstances. Nevertheless, PSE-induced
differential DNA methylation correlated with deranged gene
expression along signature pathways [34]. Here, we described
disrupted or induced correlations between promoter methyla-
tion and mRNA levels for both Igf1r and Igf1. The divergent
CpG site-speciﬁc methylation status after PSE suggests a contri-
bution to disturbed gene expression. The ﬁndings in liver, espe-
cially three days after birth, match the general association of
hyper-/hypo-methylation and gene silencing/activation. Hyper-
methylation mainly in liver of male fetuses, combined with the
inverse correlations at three CpG sites in males but not in
females could explain the sex-dependent reduction of Igf1
mRNA levels in male mice. The results obtained for the lung
can only partially explain the general smoke effect on Igf1r
mRNA in fetal lung and the lack of PSE-response in neonatal
lung by a link between mRNA levels and promoter methyla-
tion. However, it may indicate that organ-speciﬁc expression of
genes may be regulated differently. Our data together with the
correlation analysis suggest that DNA methylation and gene
expression in lung and liver of mouse fetuses and neonates may
be linked, dependent on the location of the CpG site, but also
dependent on the offspring’s sex.
In light of these observations, it is important to note that the
physical occurrence of DNA methylation in the context of gene
sequence may play a role in its regulation or reﬂect its effect in
transcription. The level of gene expression is in general
inversely correlated with DNA methylation in promoter
regions whereas methylation in the body of genes has been
Table 3. (Continued )
Correlation of / with Igf1 (2¡DCT) E17.5 lung
All All male All
female
All
control
All PSE Male
control
Male
PSE
Female
control
Female
PSE
P
value
ns <0.05 ns ns ns ns ns ns ns
CG-1212 r -0.17 -0.28 -0.01 -0.27 -0.02 0.00 -0.11 -0.28 0.14
P
value
ns ns ns ns ns ns ns ns ns
CG-1180 r -0.12 -0.17 -0.05 -0.15 -0.02 0.10 -0.02 -0.29 0.11
P
value
ns ns ns ns ns ns ns ns ns
Correlation of / with Igf1
(2¡DCT)
D3 liver
All All male All
female
All
control
All PSE Male
control
Male
PSE
Female
control
Female
PSE
Igf1 promoter methylation
[%]
CG-1509 r -0.22 0.25 0.47 0.27 -0.22 0.50 -0.13 -0.31 -0.30
P
value
ns ns <0.05 ns ns ns ns ns ns
CG-1465 r -0.07 -0.06 -0.23 0.28 -0.10 0.00 0.11 0.37 -0.38
P
value
ns ns ns ns ns ns ns ns ns
CG-1430 r -0.60 -0.53 -0.52 -0.55 -0.37 -0.52 -0.40 -0.65 -0.11
P
value
<0.001 <0.05 <0.05 <0.01 ns ns ns ns ns
CG-1357 r -0.48 -0.23 -0.38 -0.17 -0.16 -0.10 0.01 -0.25 -0.36
P
value
ns ns ns ns ns ns ns ns ns
CG-1341 r -0.05 0.03 -0.18 -0.01 -0.17 0.34 -0.08 -0.20 -0.26
P
value
ns ns ns ns ns ns ns ns ns
CG-1254 r -0.80 -0.73 -0.89 -0.75 -0.63 -0.69 -0.62 -0.95 -0.73
P
value
<
0.0001
<0.001 <0.001 < 0.001 <0.01 ns ns <0.05 <0.05
CG-1212 r -0.52 -0.49 -0.65 -0.49 -0.29 -0.42 -0.30 -0.57 -0.28
P
value
<0.01 <0.05 <0.05 ns ns ns ns ns ns
CG-1180 r -0.52 -0.57 -0.47 -0.52 -0.41 -0.50 -0.48 -0.60 -0.19
P
value
<0.001 <0.05 <0.05 <0.05 ns ns ns ns ns
ns: non signiﬁcant
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correlated with increased transcription [35]. While the
described associations between complete (de)methylation and a
gene ‘being switched on or off’ account for large differences in
methylation levels, a new paradigm focuses on small DNA
methylation changes. Those are often caused by environmental
inﬂuences, at limited genomic regions or CpG site speciﬁc, and
during period of epigenetic sensitivity (see for a review [36]).
Following this model, these small methylation differences, simi-
lar to our ﬁndings, often reach only 1–5% but are sufﬁcient to
disturb the “ﬁne-tuning” of a gene methylation signature and
thereby become the hallmark of non-malignant disorders.
These small methylation changes are also found in analyses of
newborns born to smoking mothers [37,38] and were
described, for example, for allergic asthma in adults and chil-
dren [39]. It needs to be stressed, however, that it is currently
unknown how large the biological consequences of these small
but consistent differences are.
The organ-speciﬁc ﬁndings stress the limited signiﬁcance of
analyses in blood-derived (human) samples regarding the dis-
play of the possible smoking-associated effects in the fetus itself.
Table 4. Correlation between Igf1r and Igf1 mRNA concentration in fetal and neonatal lung and liver
Correlation of Igf1r with Igf1
All All All Male Female
Male Female Control PSE Control PSE Control PSE
Lung Fetal r 0.67 0.71 0.77 0.87 0.72 0.69 0.79 0.87 0.58
P value < 0.0001 <0.001 <0.001 < 0.0001 <0.001 <0.05 <0.01 <0.001 <0.05
D3 r 0.85 0.78 0.87 0.80 0.81 0.76 0.78 0.76 0.86
P value < 0.0001 <0.001 <0.001 <0.001 0.001 <0.05 <0.01 <0.05 <0.001
Liver Fetal r 0.60 0.74 0.60 0.81 0.51 0.92 0.52 0.82 0.47
P value < 0.0001 < 0.0001 <0.01 < 0.0001 <0.05 <0.0001 ns <0.01 ns
D3 r 0.71 0.83 0.78 0.67 0.68 0.55 0.91 0.83 0.47
P value < 0.0001 <0.001 <0.0001 <0.001 <0.001 ns <0.001 <0.05 ns
Table 5. Bisulﬁte ampliﬁcation (F/R) and sequencing (S) primers
Gene
Targeted
CpG site position Sequences 5’ – 3’
Igf1 1509-1430
Amplicon
length [bp]
209
F: AGAGGGTTGGAAAGAGTTTAAG
R: AAACCAAACTTACCTCAATCTCTTAC
S1: AGGTTTTTATTTATGGGG
S2: GTATTTTTAAATTTTTTTGAGA
Sequence to analyze:
S1:
TAGYGTAAAGAGGTAGTGTAGAGTTTTTAATTGGTTTT
TGTTTTTATYGATGTGTTAGTATTTTTAAATTTTTTTGAGA
S2:
GTTYGAGAGAGTAAGAGATTGAGGTAAGT
1357–1254
Amplicon
length [bp]
212
F: AGAGTAAGAGATTGAGGTAAGTT
R: TTACCACAAAAAATAAAATTCTAATCTTC
S1: GGGAAAGTATATTTGGAG
S2: TTATTGAGAAATAGGTATAAAT
Sequence to analyze:
S1: AGATATTYGTGGAAAGTATGTAGYGTTTAATTTGGGTTTTTGTAATT
TTTTTTTATAATTTATTTTTTTATTTATTGTTTTTGAAAGATTATTGAGAAATAGGTATAAAT
S2:
YGTATTAATAGAAGATTAGAATTTTA
1212–1180
Amplicon
length [bp]
250
F: TTGGAGAGATATTAGTGGAAAGTATGTAG
R: AATTATAATATCATTCAAATCCCTCAACT
S: AGAATTTTATTTTTTGTGGTAAAG
Sequence to analyze:
GYGAGTTTATATATTATAAATAGTAGAAGTAGTYGGTTTGAATTATGTTGTTAGTTATT
Gene Targeted
CpG site position
Sequences 5’ – 3’
Igf1r 272-164
Amplicon
length [bp]
327
F: GGGGATTTTTTTTAGGAGTTAGATTTTA
R: ATTTTCCTCCTTCTTCTACATCT
S1: TTA TTT GGG ACG AAA TTT
S2: GATAAGGAGGGTGG
S3: GGAGTYGGGAAGT
Sequence to analyze:
S1: TTTTTATTTTYGTTTAAAAATAAGAGYGTAGGYGAYGATTTTYGGAAAGYGGYGTGGATAAGGAGGGTGG
S2: YGYGGGGYGGTTTTTTAGYGTYGGTAGTAGYGGTTTAYGGGGYGGYGGAGTYGGGAAGT
S3: YGGGGYGYGTYGGGGYGGGTTGTYGGYGTYGTYGGTTTTTATTTGTAAAYGTA
GAGATGTAGAAGAAGGAGGAAA
17
Amplicon
length [bp]
120
F: AGTGAGGATTGAGTTGGAGATTT
R: CCTCCCAAACCAAACTTCATTCCTTTTAT
S: ATTTTTGAGAAAAGGGAATT
Sequence to analyze:
TYGTTTTAAATAAAAGGAATGAAGTTT
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It appears that those assessments may not necessarily represent
the actual outcome of PSE in the offspring. Given that a simi-
larly designed experimental approach in humans would be
unethical, the here-described data indicate the absolute neces-
sity for fundamental (in vivo) research on functional epigenetic
links. They further indicate the need of longitudinal studies for
a more accurate display of developmental and health conse-
quences due to pregnancy smoking. Although we evaluated the
methylation states of Igf1r and Igf1 gene promoters, subsequent
analyses should include other putative regulatory regions and,
for example, equally important changes on the chromatin level
as suggested by Bauer et al. [40] In addition, in future studies it
seems necessary to differentiate more precisely between differ-
ent cell types within one organ, to reach the basic level of epige-
netic regulation. This would, on the long run, allow identifying
cell-speciﬁc methylation effects vs. more systemic changes.
Ultimately, this would then allow a more mechanistic interpre-
tation of the human data obtained with blood cells only.
Regarding the magnitude of the described differences, in partic-
ular when comparing fetuses and neonates, the reader should
note that both time points mark an interval of a few days. Dur-
ing this time frame both organs are still developing and
undergo extensive structural changes immediately after birth.
Thus, time point differences due to a diverse cellular composi-
tion (e.g., proportion of cell types, number of cells, differentia-
tion status) should be taken into account, as they may be a
potential confounder within this comparison.
Conclusion
Taking together, our data show that PSE inﬂuences DNA meth-
ylation patterns of Igfr1 and Igf1 promoter regions in liver and
lung. It further disturbs, directly or indirectly, mRNA levels of
these insulin growth factor network members in both organs.
The described effects are, at speciﬁc time points, sex-dependent
and are distinct when comparing lung and liver. We conclude
that the adverse outcomes of prenatal smoke exposure are
organ-speciﬁc, rather than systemic, as one might expect (given
the indirect exposure). Additionally, the impact of PSE on
DNA methylation status and mRNA levels differs when com-
paring fetuses and neonates. This suggests varying persistence
of PSE-induced alterations. Our study emphasizes the possibil-
ity of a sex-dependent response to PSE and may serve to iden-
tify possible new epigenetic targets to further elucidate fetal
programming due to smoking during pregnancy and its biolog-
ical consequence.
Material and Methods
Animals and smoke exposure
A total of 48 female and 48 male C57BL/6J mice were obtained
from Harlan (Horst, The Netherlands) at 6 weeks of age,
housed under standard conditions with food and water pro-
vided ad libitum and at a 12 hour light/dark cycle. The experi-
mental setup was approved by the local committee on animal
experimentation (DEC6589 B & C; University of Groningen,
Groningen, The Netherlands) and under strict governmental
and international guidelines on animal experimentation.
Mainstream cigarette smoke was generated by using
Teague10 (Tobacco and Health Research Institute of the Uni-
versity of Kentucky, Lexington, KY, USA). Over a period of
7 days, randomly selected primiparous female mice were
adjusted to cigarette smoke by stepwise increasing the number
of smoked cigarettes (3R4 cigarettes; 2.45 mg nicotine/ciga-
rette) from 2 to 5 per smoking session. At adjustment day 5
after the end of the second smoking session, all female mice
were injected with PMSG (1.25 i.u.) to stimulate ovulation and,
at day 7, with hCG (1.25 i.u.) to induce ovulation, and housed
on a 1:1 mating ratio with males overnight. Mating was con-
ﬁrmed by the presence of vaginal plug the following morning.
Female mice were exposed to two air or whole body smok-
ing sessions per day, 7 days per week throughout gestation and
housed in groups. After delivery, dams and their offspring were
no longer exposed to cigarette smoke and housed individually.
Each 12 male and 12 female fetuses of 5 smoke-exposed and
4 control dams were collected at embryonic stage 17.5 (E17.5)
and dams were euthanized under anesthesia. A total of 42 pups
randomly selected from 9 smoke-exposed (11 male, 8 female)
and 10 control (11 male, 12 female) dams were euthanized at
postnatal day 3 (D3) for collection of lung and liver. The mate-
rial was immediately frozen in liquid nitrogen and stored at
-80C until further use.
Determination of genetic sex of mice
DNA from the tail of E17.5 and D3 mice was obtained by SDS
denaturation, high salt extraction, and precipitation. The
ampliﬁcation reaction was adopted from Lambert et al. [41]
and performed using two primer sets that are speciﬁc for the
genes Sry (forward: 5'-TGGTCCCGTGGTGAGAGGC-‘3,
reverse: 5 0-TATGTGATGGCATGTGGGTTCC-’3) and IL3
(forward: 5 0-GGGACTCCAAGCTTCAATCA-’3, reverse:
5 0-TGGAGGAGGAAGAAAA GCAA-’3).
Isolation of DNA and mRNA
DNA and mRNA were isolated using the AllPrep DNA/RNA
Mini Kit (Qiagen, Cat No. 80204), according to the manufac-
turer’s protocol.
Pyrosequencing-based bisulﬁte PCR analysis
For the assessment of promoter methylation levels of Igf1r and
Igf1, bisulﬁte sequencing primers were designed using PyroMark
assay design software (version 2.0, Qiagen). Selection of CpG sites
was based on manual identiﬁcation of CpG dinucleotides, using
ENSEMBL genome web browser (Ensembl 83: Dec 2015) and
transcript location for the identiﬁcation of gene promoter regions.
Analysis of mouse Igf1r gene (ENSMUSG 00000005533) was
done using transcript Igf1r-001 (ENSMUST00000005671). Mouse
Igf1 (ENSMUSG00000020053) has eight transcripts. In this study,
we focused on transcript Igf-005 (ENSMUST00000122386), as
previously discussed [11].
Extracted genomic DNA from lung and liver (500 ng) was
converted with sodium bisulﬁte (EZ DNA Methylation-
DirectTM, Zymo Research, Cat. No. D5021), following the man-
ufacturer’s instructions. In short, bisulﬁte conversion was
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carried out in the dark at 98C for 10 minutes and 64C for
3.5 hours followed by desulphonation of the converted DNA.
Gene ampliﬁcation was done using HotStarTaq MasterMix
Kit (Qiagen, Cat. No. 203443). Further speciﬁcations on ampli-
ﬁcation conditions and primer sequences are listed in Table 5.
Ampliﬁcation conditions: 95C for 15 min, 94C for 30 s, 59C
for 30 s, 72C for 30 s, 40 cycles in a reaction volume of 25 mL.
To assess DNA methylation levels of Igf1 and Igf1r promoter
methylation, bisulﬁte sequencing was performed on the Pyro-
MarkQ24 (Qiagen) instrument. Relative levels of methylation
at each CpG site were analyzed with PyroMark Q24 2.0.6
software.
mRNA expression analysis
Quantitative PCR for mRNA levels was performed using
TaqMan Fast Advanced Master Mix (Thermo Fisher Scien-
tiﬁc, Cat. No. 4444964) with commercially available primers
for target genes Igf1r (Applied Biosystems, Mm00802831_m1)
and Igf1 (Applied Biosystems, Mm00439560_m1). Detection of
ampliﬁcation reactions were performed using Step One Plus
RealTime PCR System (Applied Biosystems) with cycling con-
ditions as follows: 95C for 20 s, 40 cycles of 95C for 1 s, 60C
for 20 s. Reactions were performed in triplicate and normalized
to housekeeping gene Gapdh (Applied Biosystems,
Mm99999915_g1).
In fetal lung, we excluded 3 out of 48 data points for Igf1,
and 1 out of 48 for Igf1r; in fetal liver, we excluded 1 out of 48
for Igf1, and 3 out of 48 for Igf1r; in neonatal lung, we excluded
1 out of 42 data points for Igf1, 2 out of 42 for Igf1r mRNA lev-
els; in neonatal liver, we excluded 5 out of 42 data points for
each Igf1 and Igf1r due to large differences between target and
housekeeping gene.
Calculations and statistical methods
Relative gene expression (2¡DCt method) as well as mean per-
cent methylation and standard error of the mean (SEM) were
calculated in Microsoft Ofﬁce Excel 2003. DNA methylation
data and mRNA levels were tested for normal distribution of
residuals (IBM SPSS version 22 release 22.0.0.1). As only
around half of the data set was normally distributed, we
decided not to analyze upon factor interaction of the offspring’s
sex and the type of exposure but evaluate all analyzed parame-
ters in the subgroups via two-tailed Mann-Whitney U-test. A
correlation of both percent methylation and target gene mRNA
levels in fetal and neonatal lung and liver was assessed using
nonparametric Spearman correlation test. P values 0.05 were
considered signiﬁcant. Since our comparative analysis approach
was hypothesis driven, and in order to present the reader all the
results, we did not adjust our signiﬁcance levels for multiple
testing, as suggested by ref. [42].
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